Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) today announced that patient testing has begun on the HealthTab(TM) platform in select Shoppers Drug Mart(R) pharmacies. According to the update, participating Shoppers Drug Mart(R) pharmacies have now received their HealthTab(TM) systems and will begin offering screening tests to patients already identified as diabetics or with known conditions associated with pre-diabetes to provide diagnostic support and pharmacist-led consultation services. “We are very excited to pilot point-of-care testing with HealthTab and the Afinion 2 analyzer at select Shoppers Drug Mart(R) pharmacies,” said Frank Hack, director of Complex Care at Shoppers Drug Mart. “We are committed to improving access to care through our pharmacy network and enabling our pharmacists to drive improved patient outcomes by providing value-added patient care services.”
To view the full press release, visit
https://ibn.fm/p3yXA
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit
www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at
https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.